GlucoSitter by DreaMed Diabetes is an automated, closed loop, artificial pancreas system for controlling glucose levels. It links the glucose sensor with the insulin pump through control algorithms. Glucose sensor data is analyzed and the pump is directed to deliver the correct dose of insulin.
GlucoSitter has been tested on 220 patients with 15,000 hours of day and night use. Medtronic will now incorporate the DreaMed algorithm in its insulin pumps.
Wearable Tech + Digital Health NYC 2015 – June 30 @ New York Academy of Sciences. Register now and save $300.